佛慈制药紧急捐赠1800盒药品驰援中国香港

Core Viewpoint - The company, Lanzhou Foci Pharmaceutical Co., Ltd., has actively responded to a fire disaster in Hong Kong by providing emergency assistance and support to affected residents [1][2]. Group 1: Emergency Response - Following a level five fire in Hong Kong's Tai Po district, the company initiated its emergency response mechanism immediately [1]. - The company coordinated with its Hong Kong subsidiary to gather aid supplies for disaster relief [1]. Group 2: Local Operations and Support - The Hong Kong subsidiary conducted safety checks for employees, their families, and nearby community residents on the night of the fire [1]. - The subsidiary effectively collaborated with local rescue organizations and Chinese medicine experts to address respiratory symptoms among the affected population [1]. Group 3: Aid Distribution - The rescue team selected "Foci Mingshan Qingqi Huatan Wan," a medicine known for its lung-clearing and phlegm-reducing properties, as the aid product [1]. - On November 27, 1,800 boxes of the selected medicine were delivered to a designated shelter and distributed to affected individuals by staff and volunteers [1]. Group 4: Ongoing Commitment - The company expressed its ongoing concern for the safety of Hong Kong residents and its commitment to support the recovery efforts [2].